Pacific Biosciences of California Long Term Deferred Charges (Quarterly) Analysis

Pacific Biosciences of California, Inc. (PACB)

1.84 -0.03 (-1.60%) USD | NASDAQ | Jan 02, 16:00

1.85 +0.01 (+0.54%) Pre-Market: 20:00

View Long Term Deferred Charges (Quarterly) for PACB.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Long Term Deferred Charges (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Long Term Deferred Charges (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Long Term Deferred Charges (Quarterly) Benchmarks

Start Trial

Twist Bioscience Corp.	--
Bruker Corp.	--
ICU Medical, Inc.	--
West Pharmaceutical Services, Inc.	--
Intellia Therapeutics, Inc.	--